Department of Environmental Science, University of Siena, Siena, Italy ; Institute of Biomechanics, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland. Abstract Introduction: A common drawback of many anticancer therapies is non-specificity in action of killing. We investigated the potential of ultra-low intensity and frequency pulsed electromagnetic fields (PEMFs) to kill breast cancer cells. Our…
Category: Oncology and Cancer
Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.
Br J Cancer. 2011 Aug 23;105(5):640-8. doi: 10.1038/bjc.2011.292. Epub 2011 Aug 9. Abstract BACKGROUND: Therapeutic options for patients with advanced hepatocellular carcinoma (HCC) are limited. There is emerging evidence that the growth of cancer cells may be altered by very low levels of electromagnetic fields modulated at specific frequencies. METHODS: A single-group, open-label, phase I/II…
Ca2+ and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF
Amplitude Modulated Radio Frequency ElectroMagnetic Field (AM RF EMF) EBioMedicine. 2019 Jun; 44: 194–208. Published online 2019 May 23. doi: 10.1016/j.ebiom.2019.05.038 Abstract Background Brain metastases are a major cause of death in patients with metastatic breast cancer. While surgical resection and radiation therapy are effective treatment modalities, the majority of patients will succumb from disease…
Response of neuroblastoma cells to RF currents as a function of the signal frequency
BMC Cancer. 2019; 19: 889. Published online 2019 Sep 5. doi: 10.1186/s12885-019-6090-6 Abstract Background Capacitive-resistive electric transfer (CRET) is a non-invasive therapeutic strategy that applies radiofrequency electric currents within the 400–600 kHz range to tissue repair and regeneration. Previous studies by our group have shown that 48 h of intermittent exposure to a 570 kHz CRET signal at…
Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies
Jacquelyn W. Zimmerman,1 Hugo Jimenez,1 Michael J. Pennison,1 Ivan Brezovich,2 Desiree Morgan,3 Albert Mudry,4 Frederico P. Costa,5 Alexandre Barbault,6 and Boris Pasche1 Author information Article notes Copyright and License information Disclaimer 1Division of Hematology/Oncology, Department of Medicine, 2Department of Radiation Oncology, 3Department of Radiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; 4Department of…
